Phathom Pharmaceuticals, Inc. (PHAT)
12.56
-1.00
(-7.37%)
USD |
NASDAQ |
Feb 27, 16:00
12.26
-0.30
(-2.39%)
After-Hours: 06:26
Phathom Pharmaceuticals Research and Development Expense (TTM) : 32.78M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| MannKind Corp. | 66.35M |
| Vanda Pharmaceuticals, Inc. | 109.27M |
| Ligand Pharmaceuticals, Inc. | 81.18M |
| Ocugen, Inc. | 35.49M |
| Rhythm Pharmaceuticals, Inc. | 166.89M |